Target intelligence / Profile preview

Molybdenum cofactor synthesis 3 pseudogene (MOCS3P)

Target
MOCS3P
Molecular classification
Other
01

Overview

The molybdenum cofactor synthesis 3 pseudogene (ENSG00000276569) is a **nonfunctional DNA sequence highly homologous to the functional MOCS3 gene**, which encodes adenylyltransferase and sulfurtransferase required for molybdenum cofactor biosynthesis[1][3][8]. Pseudogenes like this one generally do not encode functional protein products due to mutations such as frameshifts or premature stop codons, and are not considered part of conventional molecular target classes[1][3]. Though the parent gene MOCS3 is central to molybdenum cofactor biosynthesis and can be associated with metabolic pathways or rare genetic diseases, pseudogenes themselves are typically not drug targets nor direct participants in disease etiology[2][6][8]. However, some pseudogenes have been found to exhibit regulatory roles at the RNA level, potentially affecting gene expression, but there is currently no evidence that this pseudogene exerts such effects[5][7]. It is important in genome annotation and molecular studies to distinguish such pseudogenes from their functional counterparts to avoid amplification bias and misinterpretation[3]. **Note:** This entry is frequently **misannotated or misunderstood as a functional gene or target**; care must be taken to distinguish the pseudogene record from the functional *MOCS3* gene[1][3][4][8].

Other names
MOCS3Pmolybdenum cofactor synthesis 3 pseudogene 2MOCS3P1
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on Molybdenum cofactor synthesis 3 pseudogene (MOCS3P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Molybdenum cofactor synthesis 3 pseudogene (MOCS3P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call